Showing results (11-20 of 17) with videos related to
Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
The Prostate|March 14, 2022
177 Lu-PSMA radioligand therapy effectiveness in metastatic castration-resistant prostate cancer: An updated systematic review and meta-analysisMohammad S Sadaghiani, Sara Sheikhbahaei, Rudolf A Werner, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 12, 2020
Theranostics: Leveraging Molecular Imaging and Therapy to Impact Patient Management and Secure the Future of Nuclear MedicineLilja B Solnes, Rudolf A Werner, Krystyna M Jones, et al.European Urology|April 12, 2021
A Systematic Review and Meta-analysis of the Effectiveness and Toxicities of Lutetium-177-labeled Prostate-specific Membrane Antigen-targeted Radioligand Therapy in Metastatic Castration-Resistant Prostate CancerMohammad S Sadaghiani, Sara Sheikhbahaei, Rudolf A Werner, et al.Tomography (Ann Arbor, Mich.)|August 25, 2023
Detection of Biochemically Recurrent Prostate Cancer with [18F]DCFPyL PET/CT: An Updated Systematic Review and Meta-Analysis with a Focus on Correlations with Serum Prostate-Specific Antigen ParametersMohammad S Sadaghiani, Sara Sheikhbahaei, Abdullah Al-Zaghal, et al.Radiologic Clinics of North America|November 16, 2023
Prostate-Specific Membrane Antigen-Ligand Therapy: What the Radiologist Needs to KnowSteven P Rowe, Mohammad S Sadaghiani, Andrei Gafita, et al.EJNMMI Research|December 29, 2022
Deep learning and radiomics framework for PSMA-RADS classification of prostate cancer on PSMA PETKevin H Leung, Steven P Rowe, Jeffrey P Leal, et al.Kidney International|June 26, 2016
APOL1 renal-risk variants associate with reduced cerebral white matter lesion volume and increased gray matter volumeBarry I Freedman, Crystal A Gadegbeku, R Nick Bryan, et al.Pageof 2